Tong Ren Tang Technologies (HKG:1666) recorded net profit attributable to shareholders of 546.4 million yuan and operating revenue of about 5.48 billion yuan for the nine months ended Sept. 30, a Tuesday Hong Kong bourse filing said.
The detailed financial results of the pharmaceutical company will be disclosed in the unaudited third quarterly results for the nine months of the company's controlling shareholder, Beijing Tong Ren Tang.
Price (HKD): $5.34, Change: $-0.050, Percent Change: -0.93%